Operating Company Healthcare

Pro-ficiency

Research Triangle Park, North Carolina, United States

Formerly known as Pro-ficiency (a Simulations Plus company), Pro-ficiency Holdings, Inc., Simulations Plus, Inc.

Immersive, simulation-based training and performance-management platform for clinical trials, including compliance monitoring and analytics. Operates as part of Simulations Plus following the Simulations Plus acquisition of Pro-ficiency.

Focus Areas
Immersive simulation-based learning & training, Clinical trial compliance monitoring, Performance management / predictive analytics

Tracked deals

3

3 tracked deals across 2022-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

2 buyout · 1 addon

Pro-ficiency Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Pro-ficiency. 1 2022 1 2023 1 2024

Supporting Data

Recent Transactions

  • Buyer
    Simulations Plus, Inc.
    Target
    Pro-ficiency Holdings, Inc. (Pro-ficiency)
    Seller
    QHP Capital, L.P., Pro-ficiency minority shareholders
    Type
    Buyout

    Simulations Plus, Inc. (Nasdaq: SLP) has acquired Pro-ficiency Holdings, Inc. and its subsidiaries from QHP Capital, L.P. and Pro-ficiency's minority shareholders for approximately $100 million in cash. The deal expands Simulations Plus' offerings across the drug development continuum by adding Pro-ficiency's simulation-enabled training, compliance, analytics and medical communications capabilities to its biosimulation platform.

  • Buyer
    Pro-ficiency
    Target
    Compass Group Partners
    Type
    Buyout

    Pro-ficiency has acquired Compass Group Partners and affiliated assets to combine its simulation-based training platform with Compass's life-sciences medical communications capabilities. The deal expands Pro-ficiency's simulation offerings into medical affairs and commercial markets, enabling immersive simulation solutions for pharma and biotech customers and creating new revenue opportunities.

  • Buyer
    Pro-ficiency
    Target
    Fugitive Labs
    Type
    Addon

    Pro-ficiency has acquired all life-sciences intellectual property and the associated team of Fugitive Labs, bringing Fugitive's product development capabilities and team (led by Erik Guffrey) into Pro-ficiency's platform. The deal expands Pro-ficiency's product development capacity for clinical-trials simulation and performance-management products and is the company's first acquisition since being funded by NovaQuest Private Equity in 2021.

Related Acquisition Pages

Selling a company? Get in front of buyers like Pro-ficiency

Turn tracked acquisition activity into an outreach-ready buyer list.